WHO Celebrates As World's First Ebola Vaccine Gets EU Approval

Henrietta Strickland
October 20, 2019

European drugs regulators on Friday approved the world's first Ebola vaccine, a move, which has been hailed by the World Health Organisation as a "triumph for public health" that would save many lives and ensure people are protected.

There are now no therapies approved for Ebola and data from trials and compassionate use programs have shown Ervebo to be effective in protecting against the virus following a single dose, the EMA said.

"This is an important step towards relieving the burden of this deadly disease", said Guido Rasi, EMA's Executive Director. "Public health authorities in countries affected by Ebola need safe and efficacious medicines to be able to respond effectively to outbreaks and save lives".

Ebola virus disease is a rare but severe illness caused by the Ebola virus.

This is the second largest Ebola outbreak in history, after a 2013-16 epidemic in West Africa that killed more than 11,300.

Over 2,100 people have been killed by Ebola in the Democratic Republic of Congo since the middle of a year ago.

The World Health Organization says the first fully licensed doses will only be available from mid-next year.

The European Medicines Agency (EMA) said https://bit.ly/2MrRw4c its human medicines committee (CHMP) has recommended granting conditional marketing authorization in the European Union for the vaccine to be branded as Ervebo for individuals 18 and older and at risk of contacting the Zaire Ebola virus.

Ebola virus causes haemorrhagic fever and spreads from person to person through direct contact with body fluids.

There are now no licensed treatments for the deadly infection, but scientists said in August they were a step closer to being able to cure it after two experimental drugs showed survival rates of as much as 90 per cent in a clinical trial in Congo.

Other reports by Click Lancashire

Discuss This Article

FOLLOW OUR NEWSPAPER